STOCK TITAN

Ginkgo Bioworks Announces Participation in Upcoming Conferences

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) announced its participation in notable upcoming conferences, enhancing its visibility in the biotech sector. The events include the Truist Securities AI Symposium on March 1, 2022, Cowen 42nd Annual Health Care Conference on March 8, 2022, featuring a fireside chat and a panel discussion, and the HSBC Build with Bio Conference on March 10, 2022. Interested parties can find more information, webcast links, and presentation replays on the company's investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – DNA

+7.96%
+7.96% Session move

In the trading session that priced this news, DNA gained 7.96%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BOSTON, Feb. 24, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences:

  • Truist Securities AI Symposium - Biotech & Tools on Tuesday, March 1, 2022, at 9:00 a.m. ET
  • Cowen 42nd Annual Health Care Conference 
    • Fireside chat on Tuesday, March 8, 2022, at 2:10 p.m. ET
    • Synthetic Biology Enabling Drug Discovery panel on Tuesday, March 8, 2022, at 3:30 p.m. ET
  • HSBC Build with Bio Conference on Thursday, March 10, 2022, at 8:30 a.m. ET

Further details, webcast links, and replays of the presentations, if available, can be accessed on the company's investor relations website at https://investors.ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com

MEDIA CONTACT:

press@ginkgobioworks.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-upcoming-conferences-301489421.html

SOURCE Ginkgo Bioworks

FAQ

What conferences is Ginkgo Bioworks participating in March 2022?

Ginkgo Bioworks will participate in the Truist Securities AI Symposium on March 1, the Cowen 42nd Annual Health Care Conference on March 8, and the HSBC Build with Bio Conference on March 10, 2022.

What is the stock symbol for Ginkgo Bioworks?

The stock symbol for Ginkgo Bioworks is DNA.

When is the Cowen 42nd Annual Health Care Conference scheduled?

The Cowen 42nd Annual Health Care Conference is scheduled for March 8, 2022.

What time is Ginkgo's fireside chat at the Cowen conference?

Ginkgo's fireside chat is scheduled for 2:10 p.m. ET on March 8, 2022.

Where can I find more information about Ginkgo Bioworks' conference participation?

More information, including webcast links and presentation replays, can be found on Ginkgo Bioworks' investor relations website.